IRAP is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
==== MeSH D12.125.166 – amino acids, sulfur ==== MeSH D12.125.166.175 – cystathionine MeSH D12.125.166.215 – cysteic acid MeSH D12.125.166.230 – cysteine MeSH D12.125.166.230.259 – acetylcysteine MeSH D12.125.166.230.310 – carbocysteine MeSH D12.125.166.230.330 – cysteinyldopa MeSH D12.125.166.230.369 – cystine MeSH D12.125.166.230.700 – selenocysteine MeSH D12.125.166.388 – ethionine MeSH D12.125.166.498 – homocysteine MeSH D12.125.166.498.050 – s-adenosylhomocysteine MeSH D12.125.166.554 – homocystine MeSH D12.125.166.676 – methionine MeSH D12.125.166.676.180 – s-adenosylmethionine MeSH D12.125.166.676.450 – n-formylmethionine MeSH D12.125.166.676.450.440 – n-formylmethionine leucyl-phenylalanine MeSH D12.125.166.676.620 – methionine sulfoximine MeSH D12.125.166.676.620.125 – buthionine sulfoximine MeSH D12.125.166.676.900 – selenomethionine MeSH D12.125.166.676.950 – vitamin u MeSH D12.125.166.786 – penicillamine MeSH D12.125.166.786.500 – s-nitroso-n-acetylpenicillamine MeSH D12.125.166.800 – thiopronine MeSH D12.125.166.893 – thiorphan
The oxygen stable isotope system is based on the 18O/16O (δ18O) ratio in a given material, which is enriched/depleted relative to a standard. The field typically normalizes to both Vienna Standard Mean Ocean Water (VSMOW) and Standard Light Antarctic Precipitation (SLAP). This system is famous for its use in paleoclimatic studies but it also a prominent source of information in bioarchaeology. Variations in δ18O values in skeletal remains are directly related to the isotopic composition of the consumer's body water. isotopic composition of mammalian body water is primarily controlled by consumed water. δ18O values of freshwater drinking sources vary due to mass fractionations related to mechanisms of the global water cycle. Evaporated water vapor is more enriched in 16O (isotopically lighter; more negative delta value) compared to the remaining water, which is depleted in 16O (isotopically heavier; more positive delta value). An accepted first-order approximation for the isotopic composition of animal drinking water is local precipitation, though this is complicated to varying degrees by confounding water sources like natural springs or lakes. The baseline δ18O used in archaeological studies is modified depending on the relevant environmental and historical context. δ18O values of bioapatite in human skeletal remains are assumed to have formed in equilibrium with body water, thus providing a species-specific relationship to oxygen isotopic composition of body water.
I.E.M. (album) Inborn error of metabolism In-ear monitors, devices used by musicians, audio engineers and audiophiles to listen to music Incredible Expanding Mindfuck (Music) Information Engineering Methodology Institute of Electronic Music and Acoustics (Institut für Elektronische Musik und Akustik), part of the University of Music and Performing Arts, Graz Institute of Engineering and Management Integrated Enterprise Modeling Institute of Engineering in Medicine, part of the University of California, San Diego Institute for Experimental Mathematics, a central scientific facility of the University of Duisburg-Essen Intel Extreme Masters, a series of international esports tournaments International emergency medicine Internet Explorer Mobile Ion evaporation model, a model explaining electrospray ionization in mass spectrometry Iowa Electronic Markets Internal Energy Market, of the European Union
=== Actinium-227 === Actinium-227 is the most stable isotope of actinium, with a half-life of 21.772 years. It mainly (98.62%) undergoes beta decay, but sometimes (1.38%) it will undergo alpha decay instead. 227Ac is a member of the actinium series. It is found only in traces in uranium ores – one tonne of uranium in ore contains about 0.2 milligrams of 227Ac. 227Ac is prepared, in milligram amounts, by the neutron irradiation of 226Ra in a nuclear reactor.
Sources: en.wikipedia.org
=== Modern era === In the 16th century Aquileia fell under the Habsburg County of Gorizia (later the Princely County of Gorizia and Gradisca), a part of the Holy Roman Empire. The patriarchal diocese was finally officially suppressed in 1751, and the sees of Udine and Gorizia were established from its territory. During the Napoleonic Wars Aquileia was annexed to the Napoleonic Kingdom of Italy by the 1807 Treaty of Fontainebleau. It returned to Austrian control in 1815 following the Congress of Vienna, initially as part of the Kingdom of Illyria, then the reconstituted Gorizia and Gradisca (part of the Austrian Littoral). Following the Austro-Hungarian defeat in World War I, Aquileia passed to the Kingdom of Italy in 1920 (Treaty of Rapallo).
=== Positive staining === Unlike negative staining, positive staining uses basic dyes to color the specimen against a bright background. While chromophore is used for both negative and positive staining alike, the type of chromophore used in this technique is a positively charged ion instead of a negative one. The negatively charged cell wall of many microorganisms attracts the positively charged chromophore which causes the specimen to absorb the stain giving it the color of the stain being used. Positive staining is more commonly used than negative staining in microbiology. The different types of positive staining are listed below.
Glycogen storage disease type V (GSD5, GSD-V), also known as McArdle's disease, is a metabolic disorder, one of the metabolic myopathies, more specifically a muscle glycogen storage disease, caused by a deficiency of myophosphorylase. Its incidence is reported as one in 100,000, roughly the same as glycogen storage disease type I. The disease was first reported in 1951 by British physician Brian McArdle of Guy's Hospital, London.
Sources: en.wikipedia.org
=== Ribosomal RNA === The secondary structure of 23S is divided into six large domains, within which domain V is most important in its peptidyl transferase activity. Each domain contains normal secondary structure (e.g., base triple, tetraloop, cross-strand purine stack) and is also highly symmetric in tertiary structure; proteins intervene between their helices. At tertiary structure level, the large subunit rRNA is a single gigantic domain while the small subunit contains three structural domains. This difference reflects the lesser flexibility of the large subunit required by its function. While its core is conserved, it accommodates expansion segments on its periphery.
Spasms occur when the part of the brain that controls movement malfunctions, causing involuntary muscle activity. A spasm may be a muscle contraction caused by abnormal nerve stimulation or by abnormal activity of the muscle itself.
Barère voiced the Committee of Public Safety's support for the measures desired by the assembly: he presented a decree that was passed immediately, establishing a paid armed force of 6,000 men and 1,000 gunners "designed to crush the counter-revolutionaries, to execute wherever the need arises the revolutionary laws and the measures of public safety that are decreed by the National Convention, and to protect provisions (A force of citizen-soldiers which could go into the countryside to supervise the requisition of grain, to prevent the manoeuvres of rich égoistes and deliver them up to the vengeance of the laws)".) For that reason, twelve travelling tribunals (with moveable guillotines) were set up. Three months later, on 4 December, the departmental revolutionary armies (except in Paris) were banned on proposal of Tallien. The sections lost all rights to control their delegates and officials. On 4 March 1794, there were rumours of uprising in the Cordeliers club. The Hébertists hoped that the National Convention would expel Robespierre and his Montagnard supporters. The sans-culottes did not respond, and Hanriot refused to cooperate. On 13 March Hébert, the voice of the sans-culottes, had been using the latest issue of Le Père Duchesne to criticise Robespierre. On 18 March Bourdon attacked the Commune and the sans-culottes army. Jacques Hébert, Ronsin, Vincent, Momoro, Clootz, De Kock were arrested on charges of complicity with foreign powers (William Pitt the Younger) and guillotined on 24 March.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.